Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma

J Immunol. 1995 Jan 1;154(1):345-54.

Abstract

We analyzed the expression of the dsRNA-dependent protein kinase (PKR) during the activation of murine macrophages to the tumoricidal state by LPS and/or IFNs. LPS induced PKR expression in a dose-dependent manner at levels that were comparable with those observed in response to IFNs. By using the PKR inhibitor 2-aminopurine (2-AP), we have shown that the pathways of macrophage tumoricidal activation elicited by LPS and IFN-alpha beta, but not by IFN-gamma, included a 2-AP-sensitive step. In fact, LPS- and IFN-alpha beta-induced activation was inhibited by 2-AP, whereas the activation by IFN-gamma was not affected by the presence of the inhibitor. 2-AP did not affect the activation of protein kinase C or protein kinase A in intact cells. In the presence of 2-AP the up-regulation of IFN-beta mRNA by LPS was specifically inhibited, whereas the expression of glyceraldehyde-3-phosphate dehydrogenase mRNA or the induction of PKR remained unchanged, thereby demonstrating that 2-AP inhibited selective macrophage genes. The differential sensitivity to 2-AP suggested that the expression of a functional PKR may be required for the macrophage tumoricidal response triggered by LPS and IFN-alpha beta but not IFN-gamma.

Publication types

  • Comparative Study

MeSH terms

  • 2-Aminopurine / pharmacology
  • Animals
  • Cell Line, Transformed
  • Cytotoxicity, Immunologic / physiology
  • Enzyme Activation / drug effects
  • Gene Expression Regulation / drug effects
  • Interferon-alpha / pharmacology*
  • Interferon-gamma / pharmacology*
  • Lipopolysaccharides / pharmacology
  • Macrophage Activation / drug effects*
  • Macrophages, Peritoneal / drug effects
  • Mast-Cell Sarcoma
  • Mice
  • Mice, Inbred C57BL
  • Phosphorylation / drug effects
  • Protein Processing, Post-Translational / drug effects
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / physiology*
  • Recombinant Proteins
  • Tumor Cells, Cultured
  • eIF-2 Kinase

Substances

  • Interferon-alpha
  • Lipopolysaccharides
  • Recombinant Proteins
  • 2-Aminopurine
  • Interferon-gamma
  • Protein Serine-Threonine Kinases
  • eIF-2 Kinase